Antibody cocktail REGEN-COV Emergency Use Authorization (EUA) updated: low-dose 1200mg to treat COVID-19 patients! Antibody cocktail REGEN-COV Emergency...
COVID-19
News about COVID-19 information, situation, vaccines, drugs and treatment.
2019 Novel Coronavirus (2019-nCoV, named by WHO in January 2020 [1] ; SARS-CoV-2, named by the International Committee on Classification of Viruses on February 11, 2020).
Coronavirus is a large virus family, known to cause colds and more serious diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS) .
The new coronavirus is a new strain of coronavirus that has never been found in the human body before.
Common signs of people infected with coronavirus include respiratory symptoms, fever, cough, shortness of breath, and difficulty breathing .
In more severe cases, the infection can lead to pneumonia, severe acute respiratory syndrome, kidney failure, and even death.
There is no specific treatment for the disease caused by the new coronavirus.
However, many symptoms can be managed, so treatment should be based on the patient’s clinical condition.
In addition, supplementary care for infected people can be very effective.
Doing a good job of self-protection includes: maintaining basic hand and respiratory tract hygiene, adhering to safe eating habits, etc.
On February 11, 2020, the Director-General of the World Health Organization Tan Desai announced in Geneva , Switzerland , that the pneumonia caused by the new coronavirus was named “COVID-19” .
On February 22, the National Health Commission issued a notice that the English name of “new coronavirus pneumonia” was revised to “COVID-19” .
On March 11, WHO believed that the current COVID-19 outbreak could be called a global pandemic [9] . On April 4th, China held a national mourning event .
On August 18, China National Health Commission revised and completed the new coronavirus pneumonia diagnosis and treatment plan (trial eighth edition).
On September 3, the co-chair of the WHO Expert Group on Response and Evaluation of the New Coronary Pneumonia Epidemic announced the list of members of the expert group at a briefing by member states.
Non-viral COVID-19 vaccine delivery system Non-viral COVID-19 vaccine delivery system. In less than a year reported in December 2019,...
Cell therapy for severe COVID-19 patients: clinical trials and cost-effectiveness Cell therapy for severe COVID-19 patients: clinical trials...
Youth 5-25 times higher on myocarditis after mRNA COVID-19 vaccinated Youth 5-25 times higher on myocarditis after mRNA COVID-19...
Expert: The UK is in the early stage of the third wave of the epidemic and should be postponed to...
CanSino nasal spray COVID-19 vaccine entered Phase-2 clinical trials! What are advantages of the nasal spray COVID-19 vaccine? What...
Israel claims that myocarditis in some young men may be related to Pfizer's COVID-19 vaccine Israel: Myocarditis in...
What is Self-assembled mRNA vaccine? What is Self-assembled mRNA vaccine? Self-assembly is an important concept in materials science, and it...
Kexing COVD-19 vaccines made Brazil town 80% down on infection and deaths dropped by 95%. Small towns in Brazil becomes...
JAMA: Immunity generated by COVID-19 infection can last for at least 1 year JAMA: Immunity generated by COVID-19 infection can...
WHO puts China's Kexing COVID-19 vaccine on Emergency Use List (EUL) WHO puts China's Kexing COVID-19 vaccine on Emergency Use...
The 4th inactivated COVID-19 vaccine launched in China now The 4th inactivated COVID-19 vaccine launched in China now. ...
NEJM: The first "ineffective" COVID-19 vaccine for South African mutantion NEJM: The first "ineffective" COVID-19 vaccine for South...
Peru has the highest per capita death rate in the world after revising statistics on COVID-19 cases Peru with...
First discovery: A cytokine storm appeared after a cancer patient received COVID-19 mRNA vaccine A cytokine storm appeared after...
JAMA : China SINOPHARM releases phase 3 clinical data of two COVID-19 inactivated vaccines JAMA : SINOPHARM releases Phase...
Vietnam discovered "hybrid" mutant coronavirus: faster replication and more infectious "Hybrid" mutantions in Vietnam: faster replication and more infectious. Since...
Vietnam is encountering the big problem: COVID-19 cases soared Vietnam is encountering the big problem: COVID-19 cases soared. A...
Science: New research shows that SARS-CoV-2 infection levels are roughly the same on all age groups Sicence: SARS-CoV-2 infection...
U.S. still face medical challenges of COVID-19 sequelaes even infection down U.S. still face medical challenges of COVID-19 sequelaes...
85 people in Japan died after receiving Pfizer COVID-19 vaccines 85 people in Japan died after receiving Pfizer...
Neutralizing activity against Indian second-generation mutant strains Neutralizing activity against Indian second-generation mutant strains. On May 27, 2021,...
US FDA granted emergency use authorization for the GSK/Vir monoclonal antibody sotrovimab: early treatment of high-risk COVID-19 patients! FDA...
Cancer patients treated by PD-1 inhibitor had "cytokine release syndrome" after COVID-19 vaccination Cancer patients had "cytokine release syndrome" after...
The new coronavirus mutant strain escaped the humoral immunity, but failed to escape the cellular immune response; the second dose...
German reseachers claim to reveal the thrombosis caused by COVID-19 vaccines German reseachers claim to reveal the thrombosis caused...
Nature: After a mild COVID-19 patient recovers, the body will continue to produce antibody defenses for a lifetime Mild...
T cell guidelines for patients with COVID-19 pneumonia T cell guidelines for patients with COVID-19 pneumonia. Scientists from the...
The world's first Phase III clinical data of COVID-19 inactivated vaccine is officially released! First Phase III clinical data...
Cell: Coronavirus can trigger ADE effect and cause herd immunity failed. Cell: Coronavirus can trigger ADE effect and...